Digitalization and modernization of regulatory processes are in full swing. Exciting sessions here at DIA Europe. Fonto IAP helps pharma companies to transition from document-centric processes to a structured data centric practice. Please reach out to us at the @RWSgroup booth.

While this means that this time we have shorter release highlights and less flashy videos, we have certainly not been idle. Great things are coming up and we will continue to improve both the user and the developer experience of our product.

Fonto 8.7 is now available. We are ending this year on a stable footing! We’ve spent a good amount of time improving the code and doing preparatory work for upcoming releases. Read the full release highlights and give Fonto 8.7 a try: #fonto.

We are thrilled to share an exclusive glimpse into the journey of Sven Roosen to qualify for the Olympic decathlon. From battling injuries to breaking personal records, Sven's journey is a testament to the power of perseverance and ambition #decathlon.

Fonto IAP is your all-in-one solution for efficient, integrated, and cutting-edge content creation. #lifescience #pharma #fonto #futureofdocuments.

Developed in collaboration with leading pharma companies, Fonto IAP is the culmination of expertise from the renowned Tridion Docs component content management system and Fonto Editor, extended with the other powerful Fonto products.

Fonto Integrated Authoring Platform (IAP) seamlessly combines the power of structured and componentized content with user-friendly, data-driven authoring, using AI tools in the best possible ways.

"We release five new products to the market per year, and that number is growing. Per new drug application, our scientists spend 800 days on automatable work, i.e. collect, retype, change, insert and format content and data. That’s solved by Fonto IAP."

Achieving uniformity in coding styles is challenging. We use @geteslint, to assist us in adhering to coding standards, ensuring consistency across our codebase. Read the full post: #developers #fonto #ide #eslint #linting.

Getting ready for the session on "Smart Headless Delivery with Semantic AI and Content Components" by @cgettinger at @tekom. Join in room C10.4 #tekom #rwsattekom #structuredcontent #ai #tridion

Catch up with Maarten van Vulpen for a Fonto demonstration or schedule an appointment for a demo via And besides that, join our booth party from 6 pm today! Welcome! #fonto #tekom #rwsattekom #futureofdocuments #techdoc #tcworld #stuttgart #xml #dita.

At @tekom / tcworld? Come join us at the @RWSGroup booth, 2D22. We're more than happy to tell you everything about structured content authoring, technical documentation and the advantages of getting your subject-matter experts enabled to contribute to your publications!

Leading the charge in #PharmaDocumentation? Our latest blog post unveils how structured content authoring is the game-changer your company needs. Dive in #fonto #structuredauthoring #pharma #innovation #gpras #gpras2023.

The Fonto team is at @DeclarativeAms1 today and tomorrow. Catch up with Stef, Tom or @dr_rataplan for a good discussion or for @FontoXML swag! #da2023 #xml #amsterdam #declarative

We recently launched the Profiles feature in Fonto. In this post, @dr_rataplan describes how we implemented this in our Documentation editor!.Read the full post: #fonto #futureofdocuments #profiles.

Launch Alert! Fonto Integrated Authoring Platform (IAP) is here! Developed with top pharma companies, it's set to revolutionize content creation in pharma & life sciences. Say goodbye to delays and hello to efficiency! .🔗 #Fonto #Pharma #lifesciences.

Join us at October 23 in Brussels! #pharma #regulatory #fonto #LLMs #authoring #xml.

The era of authors using a word processor as the centerpiece of documentation processes gives way to a landscape in which humans and machines interact to turn data into readable information in an array of formats.

The rise of LLMs coincides with other developments in document creation and information submissions, such as data-standards to replace documents, the adoption of componentized and structured content-authoring, and the increased demand for compliance and traceability.

The possibility of content automatically being produced using Large Language Models will have a disrupting effect on document-centric processes in pharma. The role of subject-matter experts will shift from creation to collaborative review and approval.